ELAN
Price
$25.74
Change
+$2.06 (+8.70%)
Updated
Nov 6 closing price
Capitalization
12.86B
115 days until earnings call
Intraday BUY SELL Signals
XPH
Price
$64.75
Change
+$2.10 (+3.35%)
Updated
Nov 6 closing price
Net Assets
482.52M
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs XPH

ELAN vs XPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELAN vs. XPH commentary
Nov 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and XPH is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELAN with price predictions
Nov 06, 2026

Aroon Indicator for ELAN shows an upward move is likely

ELAN's Aroon Indicator triggered a bullish signal on November 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 207 similar instances where the Aroon Indicator showed a similar pattern. In 179 of the 207 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on ELAN as a result. In 48 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

The Moving Average Convergence Divergence (MACD) for ELAN just turned positive on October 05, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in 32 of 47 cases over the following month. The odds of a continued upward trend are 68%.

ELAN moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ELAN crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +5.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAN advanced for three days, in 174 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The 10-day RSI Indicator for ELAN moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 24 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for ELAN moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

ELAN broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. ELAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.952) is normal, around the industry mean (7.254). P/E Ratio (-62.780) is within average values for comparable stocks, (0.575). Projected Growth (PEG Ratio) (4.042) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (2.275) is also within normal values, averaging (181.047).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for XPH with price predictions
Nov 06, 2026

XPH's RSI Indicator climbs out of oversold territory

The RSI Oscillator for XPH moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In 19 of the 20 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on XPH as a result. In 77 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for XPH just turned positive on October 20, 2026. Looking at past instances where XPH's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.

Following a +2.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where XPH advanced for three days, in 268 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 63 cases where XPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for XPH entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

FUNDAMENTALS RATINGS
ELAN: Fundamental Ratings
ELAN
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELANXPH
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 18 days ago
76%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
77%
COMPARISON
Comparison
Nov 07, 2026
Stock price -- (ELAN: $25.74)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green while .

  • ELAN’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 6 TA indicator(s) are bullish.

  • ELAN’s TA Score: 6 bullish, 5 bearish.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +11.62% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.04%. For the same industry, the average monthly price growth was -9.05%, and the average quarterly price growth was +4.62%.

Reported Earning Dates

ELAN is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.04% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with PAHC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+8.70%
PAHC - ELAN
52%
Loosely correlated
-6.89%
ZTS - ELAN
47%
Loosely correlated
-3.30%
SNDL - ELAN
39%
Loosely correlated
+2.54%
PRGO - ELAN
36%
Loosely correlated
+0.89%
VTRS - ELAN
34%
Loosely correlated
+4.96%
More

XPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, XPH has been loosely correlated with NUVB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if XPH jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XPH
1D Price
Change %
XPH100%
+3.35%
NUVB - XPH
50%
Loosely correlated
-0.72%
ANRO - XPH
49%
Loosely correlated
+15.04%
OCUL - XPH
48%
Loosely correlated
+2.57%
AMRX - XPH
45%
Loosely correlated
+3.55%
ELAN - XPH
43%
Loosely correlated
+8.70%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MBOX.X0.0049740.000230
+4.84%
MOBOX cryptocurrency
FIDA.X0.0156900.000606
+4.02%
Bonfida cryptocurrency
ID.X0.0286040.000699
+2.50%
SPACE ID cryptocurrency
PENDLE.X1.6664270.010260
+0.62%
Pendle cryptocurrency
BNX.X25.227370-0.038906
-0.15%
BinaryX [Old] cryptocurrency